Simulation-guided selection of a Bayesian adaptive Phase II design for a nine-arm cilostazol-albumin trial in aneurysmal subarachnoid hemorrhage
Adnan I Qureshi, Hassan Raza, Naima Alam, Jonathan Beall, Byron J Gajewski, Renee H Martin, Jose I Suarez
Springer Nature ·
2026-11-18
· DOI 10.1186/s12874-026-03080-z
The publisher did not provide an abstract — full text is available via the link below.
Adnan I Qureshi, Hassan Raza, Naima Alam, Jonathan Beall, Byron J Gajewski, Renee H Martin et al. Simulation-guided selection of a Bayesian adaptive Phase II design for a nine-arm cilostazol-albumin trial in aneurysmal subarachnoid hemorrhage. // BMC Medical Research Methodology. – 2026. – DOI: 10.1186/s12874-026-03080-z. – URL: https://doi.org/10.1186/s12874-026-03080-z
Adnan I Qureshi, Hassan Raza, Naima Alam, Jonathan Beall, Byron J Gajewski, Renee H Martin, & Jose I Suarez (2026). Simulation-guided selection of a Bayesian adaptive Phase II design for a nine-arm cilostazol-albumin trial in aneurysmal subarachnoid hemorrhage. BMC Medical Research Methodology. https://doi.org/10.1186/s12874-026-03080-z
Adnan I Qureshi, et al. “Simulation-guided selection of a Bayesian adaptive Phase II design for a nine-arm cilostazol-albumin trial in aneurysmal subarachnoid hemorrhage.” BMC Medical Research Methodology, 2026. doi:10.1186/s12874-026-03080-z.
@article{Qureshi2026,
title = {Simulation-guided selection of a Bayesian adaptive Phase II design for a nine-arm cilostazol-albumin trial in aneurysmal subarachnoid hemorrhage},
author = {Qureshi, Adnan I and Raza, Hassan and Alam, Naima and Beall, Jonathan and Gajewski, Byron J and Martin, Renee H and Suarez, Jose I},
journal = {BMC Medical Research Methodology},
year = {2026},
doi = {10.1186/s12874-026-03080-z},
url = {https://doi.org/10.1186/s12874-026-03080-z}
}